SecSonar.com

Rani Therapeutics Holdings, Inc. (RANI)

Rani Therapeutics Holdings, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Rani Therapeutics Holdings, Inc. (RANI) is a Biotechnology company based in US with a market capitalization of $63.5M. Free cash flow was negative at -$18.8M. This page tracks RANI's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 105 employees · IPO Jul 30, 2021

Valuation

Valuation & price

$1.08 · as of May 17, 2026 · -62.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.92

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.85$1.63$0.42Jul 25Dec 25Jul 26Jul 7, 25$0.54Jul 9, 25$0.66Jul 11, 25$0.64Jul 15, 25$0.43Jul 17, 25$0.42Jul 21, 25$0.42Jul 23, 25$0.46Jul 25, 25$0.53Jul 29, 25$0.54Jul 31, 25$0.54Aug 4, 25$0.55Aug 6, 25$0.55Aug 11, 25$0.50Aug 13, 25$0.53Aug 15, 25$0.55Aug 19, 25$0.55Aug 21, 25$0.55Aug 25, 25$0.60Aug 27, 25$0.56Aug 29, 25$0.51Sep 3, 25$0.49Sep 5, 25$0.50Sep 9, 25$0.50Sep 11, 25$0.50Sep 16, 25$0.50Sep 18, 25$0.48Sep 22, 25$0.50Sep 24, 25$0.49Sep 26, 25$0.48Sep 30, 25$0.50Oct 2, 25$0.51Oct 6, 25$0.51Oct 8, 25$0.49Oct 10, 25$0.46Oct 14, 25$0.48Oct 16, 25$0.47Oct 21, 25$2.85Oct 23, 25$2.09Oct 27, 25$1.78Oct 29, 25$1.66Oct 31, 25$2.20Nov 4, 25$2.38Nov 6, 25$2.27Nov 10, 25$1.86Nov 12, 25$2.12Nov 14, 25$1.88Nov 18, 25$1.86Nov 20, 25$1.54Nov 25, 25$1.61Nov 28, 25$1.60Dec 2, 25$1.38Dec 4, 25$1.57Dec 8, 25$1.56Dec 10, 25$1.56Dec 12, 25$1.34Dec 16, 25$1.44Dec 18, 25$1.52Dec 22, 25$1.49Dec 24, 25$1.48Dec 29, 25$1.38Jan 2, 26$1.36Jan 6, 26$1.38Jan 8, 26$1.39Jan 12, 26$1.49Jan 14, 26$1.40Jan 16, 26$1.39Jan 21, 26$1.35Jan 23, 26$1.39Jan 27, 26$1.38Jan 29, 26$1.28Feb 2, 26$1.20Feb 4, 26$1.19Feb 9, 26$1.27Feb 11, 26$1.29Feb 13, 26$1.24Feb 18, 26$1.30Feb 20, 26$1.29Feb 24, 26$1.31Feb 26, 26$1.38Mar 2, 26$1.36Mar 4, 26$1.36Mar 6, 26$1.30Mar 10, 26$1.33Mar 12, 26$1.29Mar 17, 26$1.31Mar 19, 26$1.15Mar 23, 26$1.14Mar 25, 26$1.14Mar 27, 26$0.81Mar 31, 26$0.73Apr 2, 26$0.84Apr 7, 26$0.82Apr 9, 26$0.78Apr 13, 26$0.78Apr 15, 26$0.96Apr 17, 26$0.96Apr 22, 26$0.95Apr 24, 26$0.94Apr 28, 26$0.87Apr 30, 26$0.89May 4, 26$0.93May 6, 26$0.96May 8, 26$0.97May 12, 26$1.10May 14, 26$1.11May 18, 26$0.97May 20, 26$1.09May 22, 26$1.07May 28, 26$0.95Jun 1, 26$0.90Jun 3, 26$0.88Jun 5, 26$0.83Jun 9, 26$0.81Jun 11, 26$0.80Jun 15, 26$0.77Jun 17, 26$0.77Jun 22, 26$0.77Jun 24, 26$0.77Jun 26, 26$0.74Jul 2, 26$0.77
$0.4152-week range$2.85
Loading valuation history…

Fundamentals

Key fundamentals

$63.5M

Market cap

—

Revenue growth (YoY)

44.9%

Gross margin

-$18.8M

Free cash flow (USD)

-$45.4M

Net debt

Net cash position

132.3%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$979.0KFY 2020$462.0KFY 2021$2.7MFY 2022$0.00FY 2023$0.00FY 2024$1.0MFY 2025$1.6M
$979K$1.6M

Free cash flow by year

2019 → 2025

FY 2019$-27.8MFY 2020$-16.2MFY 2021$-32.8MFY 2022$-48.1MFY 2023$-52.5MFY 2024$-35.8MFY 2025$-18.8M
-$27.8M-$18.8M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 2024100.0%FY 202544.9%
100.0%44.9%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 15, 2026 (EPS $-0.04)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventEquity Inducement Plan AdoptedJun 29, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 29, 2026Filing
  • 8-K eventSecurities Purchase AgreementMay 27, 2026Filing
  • 8-K eventCFO TransitionMay 15, 2026Filing
  • Quarterly report10-Q FiledMay 15, 2026Filing

Questions

Frequently asked questions

What is Rani Therapeutics Holdings, Inc.'s market cap?

Rani Therapeutics Holdings, Inc. (RANI) has a market capitalization of $63.5M.

What is RANI's P/E ratio?

A meaningful P/E ratio is not available for RANI — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is RANI's price-to-book (P/B) ratio?

RANI trades at 1.92 times book value per share.

When did Rani Therapeutics Holdings, Inc. last report earnings?

RANI last reported earnings on May 15, 2026; the next date is not yet scheduled.

Are insiders buying RANI stock?

SEC Form 4 filings show no open-market insider buys at Rani Therapeutics Holdings, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

VRCA

Verrica Pharmaceuticals Inc.

$64.1M

ENTX

Entera Bio Ltd.

$62.3M

IMMP

Immutep Limited

$65M

IMA

ImageneBio Inc

$65.9M

MNOV

MediciNova, Inc.

$66M

CBUS

Cibus, Inc.

$66.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.